Lv41
480 积分 2021-07-07 加入
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
6小时前
已完结
Identification of a novel RET::FOXJ3 fusion in lung adenocarcinoma associated with lack of response to pralsetinib
21天前
已完结
Genetic landscape of homologous recombination repair genes in early-onset/familial prostate cancer patients
1个月前
已完结
Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial
1个月前
已完结
Updated Clinical Results From FURTHER: A Study of Firmonertinib in TKI-Naive, Advanced NSCLC With EGFR PACC Mutations
2个月前
已关闭
P3.12.38 Updated Clinical Results From FURTHER: A Study of Firmonertinib in TKI-Naive, Advanced NSCLC With EGFR PACC Mutations
2个月前
已关闭
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
2个月前
已完结
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
2个月前
已完结
MTAP loss is frequent in oncogene-driven NSCLC and may confer sensitivity to combined PRMT5 inhibitors and targeted therapies
3个月前
已完结
PP01.54: The Outcome of Pemigatinib in Advanced NSCLC With A Novel FGFR Fusion: Case Report
3个月前
已关闭
皖公网安备34019202002308
